StocksTelegraph
S&P 500—NASDAQ—DOW—RUSSELL—
NASDAQ · INCR·Healthcare

InterCure Ltd. Stock Analysis & AI Score

InterCure Ltd. (INCR) has an ST Score of 41.7 (C), driven by its Valuation (B+) and held back by its Growth (C-). Analysts rate it Buy.

Market Closed
$5.26
Prev Close
—
Market Cap
—
Day Range
—
52W Range
—
P/E
—
EPS (TTM)
—
Volume
—
Avg —
Beta
—
42
ST Score
41.7/100C

Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.

As of
AI Daily Briefing
Analysis by AI
Price History
—
Technical Indicators
FMP
Earnings Surprises
Analyst Forecast
Revenue Mix

Company Information

Employees—
CEO—
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date—
Website—
Country—
ExchangeNASDAQ

SEC Filings

Annual Report (10-K)

Filing DateAcceptedLink
Loading…

Quarterly Report (10-Q)

Filing DateAcceptedLink
Loading…
Analyst Price Target
ESG Score
Latest News

ST Score

INCR
41.7out of 100
Grade C

InterCure Ltd. (INCR) has an ST Score of 41.7 (C), driven by its Valuation (B+) and held back by its Growth (C-). Analysts rate it Buy.

Strongest
ValuationB+
Weakest
GrowthC-
All factor grades
  • ValuationB+
  • MomentumC+
  • ProfitabilityC-
  • Financial StrengthC-
  • GrowthC-
  • Piotroski4/9
Score methodology
Press Releases

Contact

INCR stock: frequently asked questions

What is INCR's ST Score?

InterCure Ltd. (INCR) has an ST Score of 41.7 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.

Is INCR a buy, hold, or sell?

Analysts rate INCR a Buy. Our ST Score grades it C (41.7/100). The ST Score is a data-driven signal, not a recommendation.

What are INCR's factor grades?

Valuation B+, Profitability C-, Financial Strength C-, Momentum C+, Growth C-.

What is INCR's valuation grade?

InterCure Ltd. (INCR) earns a valuation grade of B+, measured against Drug Manufacturers - Specialty & Generic peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.

What is INCR's growth grade?

InterCure Ltd. (INCR) earns a growth grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.

What is INCR's profitability grade?

InterCure Ltd. (INCR) earns a profitability grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.

What is INCR's financial strength grade?

InterCure Ltd. (INCR) earns a financial strength grade of C-, measured against Drug Manufacturers - Specialty & Generic peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.

What is INCR's Piotroski score?

InterCure Ltd. (INCR) has a Piotroski F-Score of 4 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.